These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35732327)

  • 1. Palmitoylation of the Alternative Amino Terminus of the BTK-C Isoform Controls Subcellular Distribution and Signaling.
    Kokabee M; Wang X; Voorand E; Alin E; Kokabee L; Khan F; Desrosiers S; Conklin DS
    Cancer Genomics Proteomics; 2022; 19(4):415-427. PubMed ID: 35732327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells.
    Wang X; Wong J; Sevinsky CJ; Kokabee L; Khan F; Sun Y; Conklin DS
    Mol Cancer Ther; 2016 Sep; 15(9):2198-208. PubMed ID: 27256378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis.
    Eifert C; Wang X; Kokabee L; Kourtidis A; Jain R; Gerdes MJ; Conklin DS
    Genes Chromosomes Cancer; 2013 Oct; 52(10):961-75. PubMed ID: 23913792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer.
    Kokabee L; Wang X; Sevinsky CJ; Wang WL; Cheu L; Chittur SV; Karimipoor M; Tenniswood M; Conklin DS
    Cancer Biol Ther; 2015; 16(11):1604-15. PubMed ID: 26383180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell receptor signaling down-regulates forkhead box transcription factor class O 1 mRNA expression via phosphatidylinositol 3-kinase and Bruton's tyrosine kinase.
    Hinman RM; Bushanam JN; Nichols WA; Satterthwaite AB
    J Immunol; 2007 Jan; 178(2):740-7. PubMed ID: 17202334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Bruton's tyrosine kinase in B cells and malignancies.
    Pal Singh S; Dammeijer F; Hendriks RW
    Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bruton's agammaglobulinemia tyrosine kinase (Btk) regulates TPA‑induced breast cancer cell invasion via PLCγ2/PKCβ/NF‑κB/AP‑1‑dependent matrix metalloproteinase‑9 activation.
    Kim JM; Park J; Noh EM; Song HK; Kang SY; Jung SH; Kim JS; Park BH; Lee YR; Youn HJ
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I.
    Sacristán C; Tussié-Luna MI; Logan SM; Roy AL
    J Biol Chem; 2004 Feb; 279(8):7147-58. PubMed ID: 14623887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. rlk/TXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases.
    Debnath J; Chamorro M; Czar MJ; Schaeffer EM; Lenardo MJ; Varmus HE; Schwartzberg PL
    Mol Cell Biol; 1999 Feb; 19(2):1498-507. PubMed ID: 9891083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells.
    Várnai P; Rother KI; Balla T
    J Biol Chem; 1999 Apr; 274(16):10983-9. PubMed ID: 10196179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential impact of BTK active site inhibitors on the conformational state of full-length BTK.
    Joseph RE; Amatya N; Fulton DB; Engen JR; Wales TE; Andreotti A
    Elife; 2020 Nov; 9():. PubMed ID: 33226337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural mechanism for Bruton's tyrosine kinase activation at the cell membrane.
    Wang Q; Pechersky Y; Sagawa S; Pan AC; Shaw DE
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9390-9399. PubMed ID: 31019091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.
    Novina CD; Kumar S; Bajpai U; Cheriyath V; Zhang K; Pillai S; Wortis HH; Roy AL
    Mol Cell Biol; 1999 Jul; 19(7):5014-24. PubMed ID: 10373551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bruton's Tyrosine Kinase and Its Isoforms in Cancer.
    Wang X; Kokabee L; Kokabee M; Conklin DS
    Front Cell Dev Biol; 2021; 9():668996. PubMed ID: 34307353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies.
    Kapoor I; Li Y; Sharma A; Zhu H; Bodo J; Xu W; Hsi ED; Hill BT; Almasan A
    Cell Death Dis; 2019 Dec; 10(12):924. PubMed ID: 31801949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic Action of Novel Bruton's Tyrosine Kinase Inhibitor BGB-3111 in Mantle Cell Lymphoma.
    Li CJ; Jiang C; Liu Y; Bell T; Ma W; Ye Y; Huang S; Guo H; Zhang H; Wang L; Wang J; Nomie K; Zhang L; Wang M
    Mol Cancer Ther; 2019 Feb; 18(2):267-277. PubMed ID: 30413649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Bruton's Tyrosine Kinase Suppresses Cancer Stemness and Promotes Carboplatin-induced Cytotoxicity Against Bladder Cancer Cells.
    Pan Y; Chiu YH; Chiu SC; Cho DY; Lee LM; Wen YC; Whang-Peng J; Hsiao CH; Shih PH
    Anticancer Res; 2020 Nov; 40(11):6093-6099. PubMed ID: 33109547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel role for Bruton's tyrosine kinase in hepatocyte growth factor-mediated immunoregulation of dendritic cells.
    Singhal E; Kumar P; Sen P
    J Biol Chem; 2011 Sep; 286(37):32054-63. PubMed ID: 21784852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment.
    Good L; Benner B; Carson WE
    Cancer Immunol Immunother; 2021 Sep; 70(9):2439-2451. PubMed ID: 33818636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switch-like activation of Bruton's tyrosine kinase by membrane-mediated dimerization.
    Chung JK; Nocka LM; Decker A; Wang Q; Kadlecek TA; Weiss A; Kuriyan J; Groves JT
    Proc Natl Acad Sci U S A; 2019 May; 116(22):10798-10803. PubMed ID: 31076553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.